Inventor · disambiguated record
Steven James Ferrara
Also filed as: FERRARA STEVEN J · FERRARA STEVEN JAMES
17 granted patents·7 pending applications·42 citations·filing 2017–2023
91Inventor score
Top patents by PatentIndex Score
24 records- 0194US11130745B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2020·Granted Sep 28, 2021·4 cites·19 claims
- 0293US11492358B1Macrocyclic indole derivativesBAYER AG·Filed 2021·Granted Nov 8, 2022·3 cites·18 claims
- 0392US10981932B2Macrocyclic indole derivativesBAYER AG·Filed 2017·Granted Apr 20, 2021·9 cites·17 claims
- 0490US11891404B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2022·Granted Feb 6, 2024·1 cites·10 claims
- 0589US10815215B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2017·Granted Oct 27, 2020·5 cites·20 claims
- 0688US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 0787US11713304B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2021·Granted Aug 1, 2023·1 cites·11 claims
- 0887US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 0986US11478451B1Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Oct 25, 2022·3 cites·16 claims
- 1086US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 1185US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 1285US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 1384US10968216B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2017·Granted Apr 6, 2021·3 cites·16 claims
- 1478US12486248B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 1562US2024109850A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1662US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1760US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 1859US11787797B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2021·Granted Oct 17, 2023·0 cites·2 claims
- 1954US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 2051US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 2150US2019307728A1Methods of treatment with a 2,4,5-trisubstituted 1,2,4-triazoloneBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2249US12338250B2Methods of preparing macrocyclic indolesBROAD INST INC·Filed 2020·Granted Jun 24, 2025·0 cites·20 claims
- 2343US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 2443US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven James Ferrara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →